Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Biomeva

Biomeva
1993 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Producer of biologic and therapeutic proteins. The company is engaged in providing contract development and manufacturing services using microbial expression technology to European and other international customers. Its services include process development for highly efficient therapeutic protein expression, compliant fermentation, purification, bulk filling, analytical testing and cell banking.

Website
Formerly Known As
Genbiotec, BioReliance Manufacturing
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Czernyring 22
  • 69115 Heidelberg
  • Germany

Biomeva Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Biomeva‘s full profile, request access.

Request full access to PitchBook

Biomeva Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DelSiTech Venture Capital-Backed Turku, Finland 0 00.000 0000000000 00.000
0000000000000 0000 Private Equity-Backed Hunt Valley, MD 000 00000 0000000 0000 00000
00 000000000000000 Private Equity-Backed Noáin, Spain 000 000.00 000000000000
0000000 Private Equity-Backed Turku, Finland 00 000000000000
000000000 Corporation Stockholm, Sweden 0000 00000 00000000 00000
To view this company’s complete list of competitors, request access »

Biomeva Executive Team (1)

Name Title Board
Seat
Contact
Info
Thomas Pultar Chief Executive Officer & Managing Director